Research - News
A UAB study suggests a new bone boosting drug is more effective than commonly used bone loss medications in preventing fractures in women with osteoporosis.
UAB’s Civitan Rett Syndrome Clinic has been named a Center of Excellence by rettsyndrome.org, one of the nation’s leading advocacy groups.
A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.
These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.
This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
UAB is joining the All of Us Research Program, an effort led by the National Institutes of Health to drive precision medicine research.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Due to the current opioid crisis, UAB Hospital has launched an Addiction Scholars Program to train health care professionals across the hospital in caring for patients with addiction issues.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
The inhibitor blocks Streptococcus mutans from sticking on the tooth surface. About 2.3 billion people worldwide have tooth decay in their permanent teeth, primarily caused by this bacteria.
UAB, Alabama’s leader in precision medicine, joins with Huntsville’s HudsonAlpha in CSER2, an NIH project to bring genomic medicine to more children with birth defects or genetic disorders.
UAB’s long-running study of cannabidiol reveals potential interactions between CBD and some commonly used anti-epileptic drugs.
The Iceberg project is the latest in a line of high-tech freezer technology UAB is working on for NASA.
Improvements in motor function and memory suggest human neurodevelopmental disorders may be amenable to treatment, even after onset of symptoms. According to a researcher, neurodevelopmental disorders with intellectual disability and autism may not need to last a lifetime.
Pediatric neurosurgeons, oncologists and molecular imaging physicians continue to work toward better diagnoses, treatments and cures for childhood cancer.
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
Antarctica’s Larsen C ice shelf has broken away from the mainland, resulting in a one-trillion ton iceberg.
The International Space Station carries a bit of Birmingham on board — high-tech freezers designed and built by the UAB School of Engineering to protect vital scientific experiments. From their mini mission control, staff and students describe the unique challenges of keeping NASA science on ice for more than 90 space missions.
The UAB study could help inform future health care management during early life and the development of interventions aimed at improving quality of life for older individuals.
This novel method improves purification of complex proteins by 10- to 500-fold, and it may aid both research and large-scale industrial production.
UAB research suggests EEG headsets, growing in popularity among consumers, need better security.
This active drug-delivery system addresses the limitations seen for the anti-cancer drug BA-TPQ — poor solubility and low bioavailability.
A new study shows that teens communicating on mobile phones with friends show stronger signs of technology addiction than when communicating with parents.
The new designation will provide training and support to researchers and students, translating ideas to market.
The new study is the first to observe consolation in adult humans. The findings help correct the impression that humans are aggressive by nature and peaceful by culture.
There will be more than 33,000 brain tumors diagnosed in Americans this year, according to the National Cancer Institute; but a UAB neurosurgeon says advances in treatment paint a brighter outlook than in years past.
An oral history of the development of monoclonal antibodies, the foundation of today's most exciting new drug therapies.
The goal is to avoid unnecessary surgery and reduce the number of biopsies of benign nodules and cancers that are unlikely to cause harm.
This is the first demonstration of donor microbes persisting in the recipient following fecal transplant, a finding made possible by a novel method to “fingerprint” individual strains of bacteria.